TI
EIGR
Telemetry Investments’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $407K | Buy |
345,000
+166,500
| +93% | +$196K | 0.64% | 39 |
|
|
2022
Q3 | $1.34M | Sell |
178,500
-99,409
| -36% | -$748K | 1.72% | 7 |
|
|
2022
Q2 | $1.75M | Buy |
277,909
+64,909
| +30% | +$409K | 2.07% | 5 |
|
|
2022
Q1 | $1.77M | Sell |
213,000
-52,000
| -20% | -$432K | 2.79% | 5 |
|
|
2021
Q4 | $1.38M | Buy |
265,000
+69,879
| +36% | +$363K | 1.77% | 8 |
|
|
2021
Q3 | $1.3M | Buy |
195,121
+39,548
| +25% | +$264K | 1.76% | 13 |
|
|
2021
Q2 | $1.33M | Buy |
155,573
+5,096
| +3% | +$43.4K | 1.82% | 13 |
|
|
2021
Q1 | $1.33M | Buy |
150,477
+21,629
| +17% | +$191K | 1.51% | 18 |
|
|
2020
Q4 | $1.58M | Buy |
128,848
+4,528
| +4% | +$55.7K | 2.68% | 5 |
|
|
2020
Q3 | $1.01M | Sell |
124,320
-30,680
| -20% | -$250K | 2.2% | 12 |
|
|
2020
Q2 | $1.49M | Buy |
155,000
+13,652
| +10% | +$131K | 4.04% | 5 |
|
|
2020
Q1 | $961K | Buy |
141,348
+5,500
| +4% | +$37.4K | 3.36% | 5 |
|
|
2019
Q4 | $2.02M | Sell |
135,848
-81,181
| -37% | -$1.21M | 6.74% | 5 |
|
|
2019
Q3 | $2.23M | Sell |
217,029
-159,006
| -42% | -$1.63M | 6.42% | 3 |
|
|
2019
Q2 | $3.99M | Buy |
376,035
+233,895
| +165% | +$2.48M | 3.08% | 2 |
|
|
2019
Q1 | $1.99M | Sell |
142,140
-10,266
| -7% | -$144K | 1.01% | 5 |
|
|
2018
Q4 | $1.55M | Buy |
152,406
+114,406
| +301% | +$1.16M | 0.99% | 12 |
|
|
2018
Q3 | $456K | Sell |
38,000
-1,000
| -3% | -$12K | 0.21% | 34 |
|
|
2018
Q2 | $476K | Buy |
+39,000
| New | +$476K | 0.18% | 42 |
|